WHO ICTRP trial
A prospective, single-arm, multicenter clinical study of transnasal endoscopic…
ChiCTR2200057570 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2200057570 |
|---|---|
| Public title | A prospective, single-arm, multicenter clinical study of transnasal endoscopic surgery combined with adjuvant immunotherapy for recurrent nasopharyngeal carcinoma |
| Scientific title | A prospective, single-arm, multicenter clinical study of transnasal endoscopic surgery combined with adjuvant immunotherapy for recurrent nasopharyngeal carcinoma |
| Primary sponsor | Eye, Ear, Nose, and Throat Hospital, Fudan University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 2 |
| Countries | China |
| Conditions | Recurrent nasopharyngeal carcinoma |
| Interventions | Group 1:Nasal endoscopic surgery combined with PD-1 inhibitor |
| Registration date | Mar 15, 2022 |
| Target size | Group 1:77 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: